MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Rating) saw a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 2,168,700 shares, a growth of 7.7% from the August 15th total of 2,014,400 shares. Based on an average daily volume of 229,900 shares, the short-interest ratio is presently 9.4 days.
MediPharm Labs Stock Performance
Shares of MEDIF stock opened at $0.06 on Tuesday. MediPharm Labs has a fifty-two week low of $0.04 and a fifty-two week high of $0.27. The stock's 50-day simple moving average is $0.06 and its 200-day simple moving average is $0.08.
Get MediPharm Labs alerts:MediPharm Labs Company Profile
(Get Rating)
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.Read More
- Get a free copy of the StockNews.com research report on MediPharm Labs (MEDIF)
- Lucid is Looking Like a Clear EV Winner
- Still Lovin' It: Investors Keep Visiting McDonald's
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
- Upwork Shares Stumble into Bargain Territory
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.